• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内质网应激信号与非酒精性脂肪性肝病发病机制。

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.

机构信息

Université Côte d'Azur, INSERM, U1065, C3M, 06200 Nice, France.

Biomedical Neuroscience Institute (BNI), Faculty of Medicine, University of Chile, Santiago, Chile; Center for Geroscience, Brain Health and Metabolism (GERO), Santiago, Chile; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.

出版信息

J Hepatol. 2018 Oct;69(4):927-947. doi: 10.1016/j.jhep.2018.06.008. Epub 2018 Jun 27.

DOI:10.1016/j.jhep.2018.06.008
PMID:29940269
Abstract

The global epidemic of obesity has been accompanied by a rising burden of non-alcoholic fatty liver disease (NAFLD), with manifestations ranging from simple steatosis to non-alcoholic steatohepatitis, potentially developing into hepatocellular carcinoma. Although much attention has focused on NAFLD, its pathogenesis remains largely obscure. The hallmark of NAFLD is the hepatic accumulation of lipids, which subsequently leads to cellular stress and hepatic injury, eventually resulting in chronic liver disease. Abnormal lipid accumulation often coincides with insulin resistance in steatotic livers and is associated with perturbed endoplasmic reticulum (ER) proteostasis in hepatocytes. In response to chronic ER stress, an adaptive signalling pathway known as the unfolded protein response is triggered to restore ER proteostasis. However, the unfolded protein response can cause inflammation, inflammasome activation and, in the case of non-resolvable ER stress, the death of hepatocytes. Experimental data suggest that the unfolded protein response influences hepatic tumour development, aggressiveness and response to treatment, offering novel therapeutic avenues. Herein, we provide an overview of the evidence linking ER stress to NAFLD and discuss possible points of intervention.

摘要

全球肥胖症的流行伴随着非酒精性脂肪性肝病 (NAFLD) 的负担不断增加,其表现从单纯性脂肪变性到非酒精性脂肪性肝炎不等,可能发展为肝细胞癌。尽管人们对 NAFLD 给予了高度关注,但它的发病机制在很大程度上仍不清楚。NAFLD 的标志是肝脏脂质的积累,这随后导致细胞应激和肝损伤,最终导致慢性肝病。在脂肪变性的肝脏中,异常脂质积累通常与胰岛素抵抗同时发生,并与肝细胞内质网 (ER) 蛋白质稳态紊乱有关。为了应对慢性 ER 应激,一种称为未折叠蛋白反应的适应性信号通路被触发,以恢复 ER 蛋白质稳态。然而,未折叠蛋白反应会引起炎症、炎症小体激活,并且在不可解决的 ER 应激情况下,导致肝细胞死亡。实验数据表明,未折叠蛋白反应会影响肝脏肿瘤的发展、侵袭性和对治疗的反应,为治疗提供了新的途径。在此,我们概述了将 ER 应激与 NAFLD 联系起来的证据,并讨论了可能的干预点。

相似文献

1
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease.内质网应激信号与非酒精性脂肪性肝病发病机制。
J Hepatol. 2018 Oct;69(4):927-947. doi: 10.1016/j.jhep.2018.06.008. Epub 2018 Jun 27.
2
[Endoplasmic reticulum stress response and pathogenesis of non-alcoholic steatohepatitis].[内质网应激反应与非酒精性脂肪性肝炎的发病机制]
Med Sci (Paris). 2020 Feb;36(2):119-129. doi: 10.1051/medsci/2020008. Epub 2020 Mar 4.
3
Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD).内质网应激相关分子机制在非酒精性脂肪性肝病(NAFLD)中的作用。
Curr Drug Targets. 2018;19(9):1087-1094. doi: 10.2174/1389450118666180516122517.
4
Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
5
Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease.内质网应激与氧化应激在非酒精性脂肪性肝病发病机制中的作用
Free Radic Res. 2015;49(12):1405-18. doi: 10.3109/10715762.2015.1078461. Epub 2015 Aug 25.
6
[ER stress and NAFLD].[内质网应激与非酒精性脂肪性肝病]
Biol Aujourdhui. 2020;214(1-2):15-23. doi: 10.1051/jbio/2020007. Epub 2020 Aug 10.
7
Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives.内质网应激与自噬在非酒精性脂肪性肝病(NAFLD)发病机制中的作用:现有证据和观点。
Curr Obes Rep. 2021 Jun;10(2):134-161. doi: 10.1007/s13679-021-00431-3. Epub 2021 Mar 22.
8
The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.渐进性人类非酒精性脂肪性肝病中脂肪毒性的适应性内质网应激反应。
Toxicol Sci. 2014 Jan;137(1):26-35. doi: 10.1093/toxsci/kft230. Epub 2013 Oct 4.
9
Endoplasmic reticulum proteostasis in hepatic steatosis.内质网蛋白稳态与肝脂肪变性。
Nat Rev Endocrinol. 2016 Dec;12(12):710-722. doi: 10.1038/nrendo.2016.124. Epub 2016 Aug 12.
10
Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.内质网应激在非酒精性脂肪性肝病发病机制中的作用
World J Gastroenterol. 2014 Feb 21;20(7):1768-76. doi: 10.3748/wjg.v20.i7.1768.

引用本文的文献

1
Copper and hepatic lipid dysregulation: Mechanisms and implications.铜与肝脏脂质代谢失调:机制及影响
World J Hepatol. 2025 Aug 27;17(8):107803. doi: 10.4254/wjh.v17.i8.107803.
2
Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosis.脂肪细胞特异性缺失gp130可预防生酮饮食诱导的肝脂肪变性。
Hepatol Commun. 2025 Aug 26;9(9). doi: 10.1097/HC9.0000000000000782. eCollection 2025 Sep 1.
3
ATF6 Alleviates Endothelial Inflammation Following Extended Hepatectomy Through Inhibition of TRIM10/NF-κB Signaling.
ATF6通过抑制TRIM10/NF-κB信号通路减轻扩大肝切除术后的内皮炎症。
FASEB J. 2025 Aug 31;39(16):e70933. doi: 10.1096/fj.202402197RRR.
4
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment.以环磷酸腺苷(cAMP)信号传导和磷酸二酯酶4为靶点治疗肝脏疾病。
Med Chem Res. 2024 Aug;33(8):1339-1353. doi: 10.1007/s00044-024-03267-3. Epub 2024 Jun 26.
5
The Cardiohepatic Axis in Metabolic Disease: Liver to Heart.代谢性疾病中的心肝轴:从肝脏到心脏。
JACC Basic Transl Sci. 2025 Jul;10(7):101309. doi: 10.1016/j.jacbts.2025.05.004.
6
Natural active botanical metabolites: targeting AMPK signaling pathway to treat metabolic dysfunction-associated fatty liver disease.天然活性植物代谢产物:靶向AMPK信号通路治疗代谢功能障碍相关脂肪性肝病
Front Pharmacol. 2025 Jul 14;16:1611400. doi: 10.3389/fphar.2025.1611400. eCollection 2025.
7
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems.肝脏脂蛋白代谢:当前和未来基于细胞的体外系统
Biomolecules. 2025 Jul 2;15(7):956. doi: 10.3390/biom15070956.
8
IGFBP1 orchestrates metabolic reprogramming to drive clear cell renal cell carcinoma progression through NR1H4-mediated lipid homeostasis disruption.胰岛素样生长因子结合蛋白1通过破坏NR1H4介导的脂质稳态来协调代谢重编程,从而驱动肾透明细胞癌进展。
Cancer Cell Int. 2025 Jul 28;25(1):284. doi: 10.1186/s12935-025-03904-w.
9
Marine-Derived Compounds: A New Horizon in Cancer, Renal, and Metabolic Disease Therapeutics.海洋来源化合物:癌症、肾脏及代谢性疾病治疗的新前沿
Mar Drugs. 2025 Jul 9;23(7):283. doi: 10.3390/md23070283.
10
The Beneficial Effects of Resveratrol on Hepatocellular Carcinoma and Nonalcoholic Fatty Liver Disease: Modulation of Apoptosis, Autophagy, Inflammation, and Oxidative Stress.白藜芦醇对肝细胞癌和非酒精性脂肪性肝病的有益作用:对细胞凋亡、自噬、炎症和氧化应激的调节
Food Sci Nutr. 2025 Jul 24;13(7):e70555. doi: 10.1002/fsn3.70555. eCollection 2025 Jul.